Objective: Experiences with the antimalarial quinacrine for systemic and cutaneous lupus erythematosus (SLE and CLE) remain under-explored. We evaluated and compared dermatologists' and rheumatologists' experiences with quinacr... ...

请注册登录后继续浏览